TY - JOUR
T1 - Early manifestations of epileptic encephalopathy, brain atrophy, and elevation of serum neuron specific enolase in a boy with beta-propeller protein-associated neurodegeneration
AU - Takano, Kyoko
AU - Goto, Kazuya
AU - Motobayashi, Mitsuo
AU - Wakui, Keiko
AU - Kawamura, Rie
AU - Yamaguchi, Tomomi
AU - Fukushima, Yoshimitsu
AU - Kosho, Tomoki
N1 - Publisher Copyright:
© 2017 Elsevier Masson SAS
PY - 2017/10
Y1 - 2017/10
N2 - Mutations in WDR45 are responsible for beta-propeller protein-associated neurodegeneration (BPAN), which is an X-linked form of neurodegeneration with brain iron accumulation. BPAN mainly affects females and is characterized by seizures and developmental delay or intellectual disability until adolescence or early adulthood, followed by severe dystonia, parkinsonism, and progressive dementia. However, rare male patients have recently been reported with hemizygous germline mutations in WDR45 and severe clinical manifestations, such as epileptic encephalopathies. We report here a 4-year-old boy presenting with profound developmental delay, non-syndromic epileptic encephalopathy, and early brain atrophy. The level of serum neuron specific enolase (NSE) was elevated, but the level of serum phosphorylated neurofilament heavy chain was not detectable. Targeted next-generation sequencing identified a de novo hemizygous splice donor site mutation, c.830+1G > A in WDR45, which resulted in a splicing defect evidenced by reverse transcriptase-PCR. Mutations in WDR45 should be considered as a cause for epileptic encephalopathies in males with profound developmental delay and brain atrophy. Furthermore, elevation of serum NSE may contribute to early diagnosis of BPAN.
AB - Mutations in WDR45 are responsible for beta-propeller protein-associated neurodegeneration (BPAN), which is an X-linked form of neurodegeneration with brain iron accumulation. BPAN mainly affects females and is characterized by seizures and developmental delay or intellectual disability until adolescence or early adulthood, followed by severe dystonia, parkinsonism, and progressive dementia. However, rare male patients have recently been reported with hemizygous germline mutations in WDR45 and severe clinical manifestations, such as epileptic encephalopathies. We report here a 4-year-old boy presenting with profound developmental delay, non-syndromic epileptic encephalopathy, and early brain atrophy. The level of serum neuron specific enolase (NSE) was elevated, but the level of serum phosphorylated neurofilament heavy chain was not detectable. Targeted next-generation sequencing identified a de novo hemizygous splice donor site mutation, c.830+1G > A in WDR45, which resulted in a splicing defect evidenced by reverse transcriptase-PCR. Mutations in WDR45 should be considered as a cause for epileptic encephalopathies in males with profound developmental delay and brain atrophy. Furthermore, elevation of serum NSE may contribute to early diagnosis of BPAN.
UR - http://www.scopus.com/inward/record.url?scp=85025426674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85025426674&partnerID=8YFLogxK
U2 - 10.1016/j.ejmg.2017.07.008
DO - 10.1016/j.ejmg.2017.07.008
M3 - Article
C2 - 28711740
AN - SCOPUS:85025426674
SN - 1769-7212
VL - 60
SP - 521
EP - 526
JO - European Journal of Medical Genetics
JF - European Journal of Medical Genetics
IS - 10
ER -